- Home
- TARA vs STKS Comparison
TARA vs STKS Comparison
Compare TARA & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- STKS
- Stock Information
- Founded
- TARA N/A
- STKS 2004
- Country
- TARA United States
- STKS United States
- Employees
- TARA N/A
- STKS N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- STKS Restaurants
- Sector
- TARA Health Care
- STKS Consumer Discretionary
- Exchange
- TARA Nasdaq
- STKS Nasdaq
- Market Cap
- TARA 118.1M
- STKS 109.7M
- IPO Year
- TARA N/A
- STKS N/A
- Fundamental
- Price
- TARA $3.03
- STKS $2.47
- Analyst Decision
- TARA Strong Buy
- STKS Hold
- Analyst Count
- TARA 6
- STKS 3
- Target Price
- TARA $19.80
- STKS $4.50
- AVG Volume (30 Days)
- TARA 148.6K
- STKS 67.6K
- Earning Date
- TARA 11-11-2025
- STKS 11-06-2025
- Dividend Yield
- TARA N/A
- STKS N/A
- EPS Growth
- TARA N/A
- STKS N/A
- EPS
- TARA N/A
- STKS N/A
- Revenue
- TARA N/A
- STKS $834,363,000.00
- Revenue This Year
- TARA N/A
- STKS $26.58
- Revenue Next Year
- TARA N/A
- STKS $5.37
- P/E Ratio
- TARA N/A
- STKS N/A
- Revenue Growth
- TARA N/A
- STKS 96.64
- 52 Week Low
- TARA $1.60
- STKS $2.37
- 52 Week High
- TARA $10.48
- STKS $5.26
- Technical
- Relative Strength Index (RSI)
- TARA 43.85
- STKS 29.41
- Support Level
- TARA $3.05
- STKS $2.43
- Resistance Level
- TARA $3.20
- STKS $2.71
- Average True Range (ATR)
- TARA 0.13
- STKS 0.13
- MACD
- TARA -0.01
- STKS 0.00
- Stochastic Oscillator
- TARA 3.33
- STKS 8.70
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.